Management of primary rectal cancer by surgeons in Atlantic Canada: Results of a regional survey

Canadian Journal of Surgery

Volumn 53, Issue 6, 2010, Pages 396-402

  Chuah, Teong Kuan ^a   Lee, Tracy ^b   Wirtzfeld, Debrah ^c   Pollett, William ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Richmond Hospital   (Canada)

^c CANCERCARE MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649767909     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics 2008. Toronto (ON); The Society; 2008.
2. McMullen TP, Easson AM, Cohen Z, et al. The investigation of primary rectal cancer by surgeons: current pattern of practice. Can J Surg 2005;48:19-26.
3. Hool GR, Church JM, Fazio VW. Decision-making in rectal cancer surgery. Survey of North American colorectal residency programs. Dis Colon Rectum 1998;41:147-52.
4. Hyman N, Healey C, Osler T, et al. Understanding variation in the management of rectal cancer: the potential of a surgeon-initiated database. Am J Surg 2007;194:559-62.
5. Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
6. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999;25:368-74.
7. Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-9.
8. Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: long-lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23:5644-50.
9. Pieterse AH, Stiggelbout AM, Baas-Thijssen MC, et al. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. Br J Cancer 2007;97:717-24.
10. Wong RK, Tandan V, De Silva S, et al. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcin - oma. Cochrane Database Syst Rev 2007;(2):CD002102.
11. Vermaas M, Ferenschild FT, Nuyttens JJ, et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 2005;48:918-28.
12. Porter GA, Soskolne CL, Yakimets WW, et al. Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998;227:157-67.
13. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991; 302:1501-5.
14. Wirtzfeld DA, Mikula L, Gryfe R, et al. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Can J Surg 2009;52:92-7.
15. Cheifetz RE, Phang PT. Evaluating learning and knowledge retention after a continuing medical education course on total mesorectal excision for surgeons. Am J Surg 2006;191:687-90.
16. Simunovic M, Goldsmith C, Thabane L, et al. The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery. BMC Surg 2008;8:4.